There are few reports on HIV-1 intra-host evolutionary rate in asymptomatic treatment-naïve patients. Here, the HIV-1 intra-host evolutionary rate was estimated based on HIV-1 RNA sequences from plasma samples of blood donors in Japan. Blood donors were assumed to have received no treatment for and have no symptoms of HIV-1 infection because they were healthy, and declared no risky behaviors of HIV-1 infection on a self-reported questionnaire or interview followed by donation. HIV-1 RNA was obtained from 85 plasma samples from 36 blood donors who donated blood multiple times and were HIV-1-positive. The C2V3C3 region which encodes for a part of the envelope protein, and the V3 loop in the C2V3C3 region were analyzed by RT-PCR and direct sequencing, and the sequences were compared. The nucleotide substitution rate was calculated by linear regression. All HIV-1 samples analyzed were classified as subtype B. The mean nucleotide substitution rate in C2V3C3 was calculated to be 6.2 × 10−3–1.8 × 10−2/site/year (V3: 4.5 × 10−3–2.3 × 10−2/site/year). The mean non-synonymous substitution rate in C2V3C3 was calculated to be 5.2 × 10−3–1.7 × 10−2/site/year (V3: 4.5 × 10−3–2.1 × 10−2/site/year). The mean synonymous substitution rate in C2V3C3 was calculated to be 1.1 × 10−4–2.3 × 10−3/site/year (V3: 2.9 × 10−3/site/year). Among HIV-1 subtype B RNA-positive blood donors in Japan, the nucleotide substitution rate in C2V3C3 was estimated to be higher than that of reported cases using HIV-1 samples mainly obtained from AIDS patients. Compared to AIDS patients, immune responses against HIV-1 are probably more effective in HIV-1 RNA-positive blood donors. Consequently, immune pressure presumably promotes mutation of the virus genome.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
D.C. Cary, K. Fujinaga, B.M. Peterlin, J. Clin. Invest. 126, 448–454 (2016)
D.S. Clutter, M.R. Jordan, S. Bertagnolio, R.W. Shafer, Infect. Genet. Evol. 46, 292–307 (2016)
W.S. Hu, S.H. Hughes, Cold Spring Harb. Perspect. Med. 2, a006882 (2012)
B. Joos, M. Fischer, A. Schweizer, H. Kuster, J. Böni, J.K. Wong, R. Weber, A. Trkola, H.F. Günthard, J. Infect. Dis. 196, 313–320 (2007)
F. Klein, H. Mouquet, P. Dosenovic, J.F. Scheid, L. Scharf, M.C. Nussenzweig, Science 341, 1199–1204 (2013)
P. Balfe, P. Simmonds, C.A. Ludlam, J.O. Bishop, A.J. Brown, J. Virol. 64, 6221–6233 (1990)
D. Edo-Matas, P. Lemey, J.A. Tom, C. Serna-Bolea, A.E. Van Den Blink, A.B. Van’T Wout, H. Schuitemaker, M.A. Suchard, Mol. Biol. Evol. 28, 1605–1616 (2011)
V.V. Lukashov, C.L. Kuiken, J. Goudsmit, J. Virol. 69, 6911–6916 (1995)
V. Novitsky, R. Wang, R. Rossenkhan, S. Moyo, M. Essex, Infect. Genet. Evol. 19, 361–368 (2013)
A. Carvajal-Rodríguez, D. Posada, M. Pérez-Losada, E. Keller, E.J. Abrams, R.P. Viscidi, K.A. Crandall, Infect. Genet. Evol. 8, 110–120 (2008)
M. Arenas, Comput. Math. Methods Med. (2015). https://doi.org/10.1155/2015/395826
P. Lemey, S.L. Kosakovsky Pond, A.J. Drummond, O.G. Pybus, B. Shapiro, H. Barroso, N. Taveira, A. Rambaut, PLoS Comput. Biol. 3, e29 (2007)
C. Matsumoto, N. Shinohara, R. Sobata, S. Uchida, M. Satake, K. Tadokoro, Jpn. J. Infect. Dis. 70, 136–142 (2017)
M. Kumura, Nature 267, 275–276 (1977)
K.J. Penrose, U.M. Parikh, K.A. Hamanishi, L. Else, D. Back, M. Boffito, A. Jackson, J.W. Mellors, J. Infect. Dis. 213, 1013–1017 (2016)
H. Barroso, P. Borrego, I. Bártolo, J.M. Marcelino, C. Família, A. Quintas, N. Taveira, PLoS ONE 6, e14548 (2011)
M.J. Dapp, K.M. Kober, L. Chen, D.H. Westfall, K. Wong, H. Zhao, B.M. Hall, W. Deng, T. Sibley, S. Ghorai, K. Kim, N. Chen, S. McHugh, L. Au, M. Cohen, K. Anastos, J.I. Mullins, PLoS ONE 12, e0182443 (2017)
F. Bielejec, G. Baele, A.G. Rodrigo, M.A. Suchard, P. Lemey, Virus Evol. 2, vew023 (2016)
J. Raghwani, S. Bhatt, O.G. Pybus, PLoS Comput. Biol. 7, e1004694 (2016)
E.L. Delwart, H. Pan, H.W. Sheppard, D. Wolpert, A.U. Neumann, B. Korber, J.I. Mullins, J. Virol. 71, 7498–7508 (1997)
Conflict of interest
The authors have no conflicts of interest to disclose.
This study was conducted according to the principles in the Declaration of Helsinki. The Japanese Red Cross Blood Service ethics committee approved the study protocol (No. 2016-023-1).
Edited by Wolfram Gerlich.
About this article
Cite this article
Shinohara, N., Matsumoto, C., Matsubayashi, K. et al. Analysis of evolutionary rate of HIV-1 subtype B using blood donor samples in Japan. Virus Genes 54, 457–460 (2018). https://doi.org/10.1007/s11262-018-1548-1
- Nucleotide substitution rate
- Blood donor
- C2V3C3 region in the env gene